Free Trial

Trellus Health (TRLS) Competitors

GBX 2.17 +0.57 (+35.50%)
As of 03/28/2025 12:41 PM Eastern

TRLS vs. FDBK, INHC, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, and RENX

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Feedback (FDBK), Induction Healthcare Group (INHC), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry.

Trellus Health vs.

Feedback (LON:FDBK) and Trellus Health (LON:TRLS) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, community ranking, analyst recommendations, institutional ownership and media sentiment.

53.2% of Feedback shares are held by institutional investors. Comparatively, 19.3% of Trellus Health shares are held by institutional investors. 10.8% of Feedback shares are held by insiders. Comparatively, 49.7% of Trellus Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, Feedback's average media sentiment score of 0.00 equaled Trellus Health'saverage media sentiment score.

Company Overall Sentiment
Feedback Neutral
Trellus Health Neutral

Feedback received 165 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%
Trellus HealthN/AN/A

Trellus Health has lower revenue, but higher earnings than Feedback. Feedback is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Feedback£3.88M1.92-£10.84M-£24.74-0.69
Trellus Health£65.83K63.67-£7.98M-£3.45-0.63

Feedback has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Comparatively, Trellus Health has a beta of 0.01, indicating that its share price is 99% less volatile than the S&P 500.

Feedback has a net margin of -279.16% compared to Trellus Health's net margin of -12,114.55%. Trellus Health's return on equity of -37.95% beat Feedback's return on equity.

Company Net Margins Return on Equity Return on Assets
Feedback-279.16% -39.71% -22.99%
Trellus Health -12,114.55%-37.95%-22.76%

Summary

Trellus Health beats Feedback on 7 of the 12 factors compared between the two stocks.

Remove Ads
Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£4.19M£204.15M£5.63B£2.61B
Dividend YieldN/A6.68%4.59%4.82%
P/E Ratio-0.63239.4723.37141.38
Price / Sales63.67502.93387.84283,159.35
Price / Cash0.7647.1438.1728.02
Price / Book0.225.216.894.62
Net Income-£7.98M-£15.55M£3.20B£5.81B
7 Day Performance20.44%-2.41%-2.99%1.42%
1 Month Performance-9.67%-7.70%1.63%7.35%
1 Year Performance-3.64%3.15%9.45%112.38%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 2.17
+35.5%
N/A-3.6%£4.19M£65,831.01-0.6331Gap Up
FDBK
Feedback
N/AGBX 17.64
+1.4%
N/A-86.9%£7.73M£3.88M-0.7124High Trading Volume
INHC
Induction Healthcare Group
N/AGBX 6.01
+0.2%
N/A-63.9%£5.55M£12.57M-1.0874Gap Down
IQAI
IQ-AI
N/AGBX 0.93
-1.1%
N/A-36.3%£2.06M£538,190.00-13.676Gap Down
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
1.786 of 5 stars
GBX 1,880
+1.1%
GBX 2,800
+48.9%
-18.4%£807.77M£230.77M69.46734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
N/AGBX 130.90
+1.5%
GBX 583.33
+345.6%
-51.3%£48.04M£50.72M12.30478
RENX
Renalytix
N/AGBX 8.75
-2.8%
N/A-74.6%£36.27M£9.22M-0.41102
Remove Ads

Related Companies and Tools


This page (LON:TRLS) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners